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Abstract 
Background: Baseline scores on a Healthy Aging Index (HAI), including 5 key physiological 
domains, strongly predict health outcomes. This study aimed to characterize 9-year changes in a 
HAI and explore their relationship to subsequent mortality.    
Methods: Data are from the Health, Aging and Body Composition study of well-functioning 
adults aged 70-79. A HAI, which ranges from 0-10, was constructed at year 1 and year 10 of the 
study including systolic blood pressure, forced expiratory volume, digit symbol substitution test, 
cystatin C and fasting glucose. The relationships between the HAI at year 1 and year 10 and the 
change between years and subsequent mortality until year 17 were estimated from Cox 
proportional hazards models.   
Results: 2264 participants had complete data on a HAI at year 1, of these 1122 had complete 
data at year 10. HAI scores tended to increase (i.e., get worse) over 9-year follow-up, from 
(mean (SD)) 4.3 (2.1) to 5.7 (2.1); mean within person change 1.5 (1.6). After multivariable 
adjustment HAI score was related to mortality from year 1 (Hazard Ratio (95% Confidence 
Interval) =1.17 (1.13 - 1.21) per unit) and year 10 (1.20 (1.14 - 1.27) per unit). The change 
between years was also related to mortality (1.08 (1.02 - 1.15) per unit change). 
Conclusions: HAI scores tended to increase with advancing age and stratified mortality rates 
among participants remaining at year 10. The HAI may prove useful to understand changes in 
health with aging.  
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Introduction 
Comorbidity indices summarize overall burden of chronic conditions and can identify older 
adults with the greatest health needs (1). The Healthy Aging Index (HAI) extends this approach 
using 5 easily measured physiological indicators sensitive to both clinical and subclinical 
changes in organ structure and function (2).  The HAI stratifies the full range of mortality rates 
and may distinguish those with low from usual rates as an intermediate endpoint for longevity 
(3) 
Many recent observations support the use of the HAI as a summary measure of physiologic 
aging.  The HAI predicts mortality independently of chronological age and comorbidity (2). This 
finding has been replicated across several samples and population subgroups, including those 
with minimal diagnosed comorbidity (4-6). The HAI has also been shown to predict onset of 
disability in well-functioning older adults and future cardiovascular disease in adults aged 60 and 
over (2, 4).  It has also been related to future decline in gait speed (7). 
Further studies have shown heritability in HAI scores among long-lived families and identified 
potential genetic correlates (5, 8). Most recently, HAI scores have been associated with 
differential metabolite profiles relevant to various age-related pathways and predictive of 
cardiovascular mortality (9).  
These findings show potential utility for the HAI as a surrogate measure of longevity for use in 
future trials targeting aging (10). Before this can happen, it is vital to establish how the HAI 
changes with chronological aging and to what extent these changes reflect variations in 
physiologic aging. A small number of studies have explored trajectories of related healthy aging 
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measures (11, 12). However, the relationships between changes in these measures and 
subsequent health outcomes are unclear. 
This study aimed to characterize 9-year changes in the HAI in well-functioning adults aging 
from their 70s to their 80s. Further, we sought to compare the change in HAI score to the score at 
a given time-point as a predictor of mortality. 
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Methods 
Participants  
The Health, Aging and Body Composition (Health ABC) Study is a prospective cohort study of 
3,075 nondisabled black (41.7%) and white men and women (51.5%) from the Pittsburgh, PA 
and Memphis, TN areas, aged 70–79 years at baseline. Eligibility criteria included, no self-
reported difficulty walking a quarter mile, climbing 10 steps, or performing mobility-related 
activities of daily living, no reported use of a walking aid, no history of cancer treatment in the 
past 3 years, and no plans to move from the area in the next 3 years. The institutional review 
boards of the University of Pittsburgh, the University of Tennessee, the University of California–
San Francisco Coordinating Center, and the National Institute on Aging approved the study and 
all participants gave informed consent. 
 
Healthy Aging Index  
The HAI was constructed as previously described at year 1 and year 10 using markers of 
cardiovascular, lung, cognitive, metabolic and kidney function (2). Kidney biomarkers were 
measured using different assays at year 1 compared to later years. To avoid potential inter-assay 
variability, cystatin C measured at year 3 was used for the year 1 score (13). The study also 
changed from desktop to handheld spirometers in year 10.  Although concerns have been raised 
over comparability of different devices (14), the 2 models used in Health ABC have been found 
to give very similar readings (15). All components were scored from 0-2 from most to least 
healthy using tertiles or clinical cut-points (2, 3). Cut-points for 4 of the components were 
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previously reported (2), cystatin C tertiles were defined based on the year 3 data. The specific 
components were: 
Systolic Blood Pressure (SBP): 0: <126 mmHg, 1: 126–142 mmHg, and 2: ≥142 mmHg.  
Forced Vital Capacity (FVC): men, 0: ≥3,700 mL, 1: 3,066–3,700 mL, 2: <3,066 mL; women, 0: 
≥2,564 mL, 1: 2,127–2,564 mL, and 2: <2,127 mL.  
Digit Symbol Substitution Test (DSST): 0: ≥42 points, 1: 30–42 points, and 2: <30 points.  
Cystatin C: 0: ≤0.77 mg/L, 1: 0.78-0.92 mg/L, 2: >0.92mg/L 
Fasting glucose: 0: <100 mg/dL, 1: 100-126 mg/dL, 2: ≥126 mg/dL (clinical cut-points 
suggested by the American Diabetes Association) 
For the SBP and glucose components participants with treated or self-reported diagnosed 
hypertension or diabetes were coded into the least healthy tertile (5). At year 10 this included 
cumulative reports. The five components were summed to give a score of 0-10 for each 
participant at each time-point.  
Mortality analysis 
Participants were followed up for mortality from study inception until September 30th 2014. A 
summary of the study design and participant flow is given in Supplemental Figure S1. Survival 
analyses for the year 1 HAI were conducted from the date of the year 3 visit (when cystatin C 
was measured). 2264 participants with a year 3 cystatin C measurement, complete data on the 
other 4 HAI components at year 1 and mortality follow-up were included in this analysis. 1359 
participants returned for a health assessment at year 10, of these 1122 with complete data for the 
HAI at year 1 and year 10 and mortality follow-up were included in these analyses. For the year 
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10 score and the change between years mortality follow-up was conducted from the date of the 
year 10 visit. . Follow-up days were defined as days from the relevant clinic visit until date of 
death or date of last contact, including all 17 years of the study. Deaths were ascertained from 
semi-annual contacts, reports from family members or review of obituaries and death records and 
adjudicated by committee from medical records, death certificate and informant interviews. 
Mean follow-up time from year 3 was 10.6 years with a maximum of 15.2 years. From year 10 
the mean follow-up time was 6.2 years and the maximum 8.2 years.   
Covariates 
Demographic covariates included age (at year 1 or year 10), sex, self-reported race, study site 
and education. Further health related covariates were chosen based on prior work and known 
relationship to mortality from the selection of variables available at years 1 and 10 (2). These 
included smoking status, body mass index (BMI) and self-reported physical activity defined as 
kcal/kg/week from walking, stair climbing and chores (16, 17). 20m gait speed was included as a 
measure of functional ability and key health indicator. Prevalence of chronic health conditions 
was estimated at years 1 and 10 based on defined algorithms. A full description of the variables 
and their coding is included in Supplementary Material.  
Statistical Analysis  
Characteristics of the year 1 and year 10 samples were summarized as mean (SD) or median 
(IQR) for continuous variables and frequency (%) for categorical variables. Distributions of the 
HAI at year 1 and 10 were explored graphically and within person change calculated as year 10 
score - year 1 score.  
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The relationships between the HAI at year 1 and year 10 and the change between years, and 
mortality were estimated from Cox proportional hazards models. The proportional hazards 
assumption was checked using the Schoenfield residuals test and comparison of fitted and 
observed survival curves. Model 1 included demographic variables: age, sex, race, study site and 
education. Model 2 additionally included BMI, smoking, physical activity, cancer, 
cardiovascular disease (CVD), pulmonary disease, depression, osteoporotic drug use and hip or 
knee osteoarthritis, and model 3 additionally included 20m gait speed. The full outputs from 
these models are included in supplemental tables S3-S5.  Harrell’s C statistics were calculated to 
compare different models at year 10.  
Additional sets of models were constructed entering the change jointly with 1) the year 1 score 
and 2) the year 10 score. This allowed us to 1) account for the relationship between the change 
and the initial score and 2) assess the relative importance of the change and the current score.  
The relationships between changes in the individual HAI components and mortality were 
modelled adjusting for the full set of covariates and for the year 10 score for that component.  
All analyses were conducted using Stata version 14.1.       
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Results 
The mean (SD) age of the sample at year 1 was 73.6 (2.8) years, 51.4% were female, 38.4% were 
black and 44.9% were educated above secondary level (Table 1). At year 10 the mean age of 
these participants was 82.1 (2.7), 50.5% had post-secondary education and 32.7% were black 
(Table 1). At year 1 they represented a healthier subset of the full sample with better scores on 
the HAI components (except SBP and fasting glucose) and lower levels of chronic disease (Table 
1). As expected with increasing age the prevalence of chronic disease was generally higher and 
scores on the HAI components generally poorer at year 10.  
The HAI was relatively normally distributed at both year 1 and year 10 (Figure 1A). In the 
matched year 1 and 10 sample, there was a shift from mainly lower scores at year 1 to higher 
scores at year 10 (Figure 1A). Within person change in the HAI was approximately normally 
distributed around a mean of 1.5, with about 3 quarters of the sample increasing their score over 
time (Figure 1B). Participants with lower scores tended to have greater increases while those 
with high scores remained more stable (Figure 1C).   
Less than 10% of participants decreased their scores over time on any one component (Table 
S1). Consistent with previous reports of limited cross-sectional correlations between the HAI 
components (2, 3), correlations between component changes were low (-0.0461-0.1071, Table 
S2).   
A total of 1436 deaths occurred during up to 15.2 years follow-up from year 3. 497 occurred 
after the year 10 assessment in the remaining sample.  The mortality gradient across the range of 
the HAI was similar at year 1 and year 10 (Figure 2), increasing from 33 events per 1000 person 
years in participants with HAI scores ≤2 to 90 events per 1000 person years in participants with 
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scores of 7-10 at year 1 and from 33 to 100 across this range at year 10 (Table 2). This graded 
relationship remained after adjustment for demographic factors at both years (Hazard Ratio (95% 
Confidence Interval) for the highest (7-10) vs lowest (0-2) scores = 2.58 (2.10-3.18) at year 1 
and 2.75 (1.68-4.48) at year 10). Hazard Ratios (95%CI) per unit higher HAI were 1.18 (1.14-
1.21) at year 1 and 1.23 (1.17-1.29) at year 10. The relationships between the HAI and mortality 
tended to be slightly stronger after adjustment for chronic conditions and health behaviors (Table 
2). This was due to the inclusion of BMI, which was positively related to several HAI 
components and negatively related to mortality. Further adjustment for gait speed slightly 
reduced the strength of relationships (Table 2).  
The change in the HAI between years was also related to mortality (HR (95% CI)=1.08 (1.02-
1.15) per unit increase in change score in the full models). Participants with the greatest increase 
had the highest mortality: HR(95%CI)=1.55 (1.11-2.16) in those gaining 4 points in the full 
models. Adjustment for the year 1 score increased the effect size for the change 
(HR(95%CI)=1.19 (1.11-1.27) per unit increase in the full models).  
Inclusion of the year 10 score and the change in the same model attenuated the relationship with 
the change with little effect on the year 10 score relationship (HR(95%CI)=0.98 (0.92-1.05) for 
the change and HR(95%CI)=1.21 (1.14-1.29) for the year 10 score in the full models). C-
statistics for the unadjusted year 10 score and change score models were 0.62 and 0.53 (Table 
S6). For the combined year 10 score and change model it was 0.62. The c-statistic for the model 
containing the year 10 score and all covariates was 0.7 and for a model containing all covariates 
without the HAI was 0.69.  
One issue in constructing a HAI is whether to count known diagnoses of hypertension and 
diabetes as the highest score. Using the values for glucose and SBP without additionally scoring 
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the condition gave lower average scores at year 1 and 10 and a slightly reduced mean change 
score of 1.1 points. Mortality estimates were similar when these conditions were adjusted for in 
the full models, instead of included in the HAI (HR (95%CI) per unit = 1.13 (1.09-1.17) for year 
1; 1.18 (1.11-1.25) for year 10; and 1.07 (1.01-1.14) for the change). 
All HAI components were related to mortality from year 1 and year 10 in all models, except SBP 
at year 10 (Supplemental Table S7). However, of the change scores at year 10, only changes in 
DSST and cystatin C were related to mortality (HR (95%CI)=1.53 (1.33-1.75) and 1.14 (1.01-
1.29) per unit increase in change score in demographic adjusted models, Table 3). These 
relationships were not greatly affected by adjustment for health covariates (Table 3). As for the 
overall change score, adjustment for year 1 score strengthened relationships with DSST (1.79 
(1.54-2.09)), Cystatin C (1.30 (1.13-1.50)) and FVC (1.26 (1.08-1.47)) in demographic models 
(not shown). Adjustment for the year 10 scores attenuated the relationship with cystatin C and 
reduced the relationship with DSST (1.22 (1.03-1.46)). Changes in SBP and glucose did not 
clearly relate to mortality in any models (Table 3). 
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Discussion 
Scores on a HAI increased at least 1 point over 9 years in 72% of adults aged in their 70s at 
baseline. The HAI score was related to mortality from year 1 and year 10. The change in HAI 
was also related to mortality, especially when accounting for differences in baseline score. 
Although this relationship could be attenuated by adjustment for year 10 score.  
Some limitations of this study should be acknowledged. There was missing data for the HAI 
components at both years 1 and 10, substantial attrition due to mortality and other causes 
occurred before year 10 and not all remaining participants could complete a health assessment. 
This limits the generalizability of findings to less healthy older adults. Survival and other biases 
introduced from missing data might be expected to lead to underestimation of the relationship 
between HAI and mortality from year 10 and to limit variation in change scores. It was only 
possible to construct a full HAI at 2 time-points and cystatin C from year 3 had to be used for the 
year 1 score, limiting the scope of analyses possible. These limitations are balanced by important 
strengths of prospective measurement of the HAI, long term follow-up for repeat measurements 
and mortality and well-validated assessments of outcomes and confounding variables.  
The HAI has been shown to stratify mortality rates in several samples of people aged 60 and 
older (4, 6, 8). Here we confirm it performs similarly in the older sample (mean age 82 years) 
remaining at year 10 of Health ABC. This effect was independent of known comorbidity and 
functional ability. Adding the HAI did not greatly increase the c-statistic for the full model. 
However, there is a limit to the classification accuracy achievable in epidemiological studies of 
complex outcomes and even apparently strong predictors may not increase these statistics for 
detailed models (18).  
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The raw change in HAI score was more modestly related to subsequent mortality. Survival bias 
is a partial explanation, with participants experiencing rapid increases in score not surviving to 
the second assessment. Additionally, interpreting change in longitudinal studies is complex. The 
change partly reflects the initial score, and the relevance of the change score is contextual with a 
small increase in a high score likely to capture a more serious or ‘later’ decline in health than a 
similar increase from a lower score. The availability of only 2 time points is particularly 
problematic as it is not possible to separate ‘true’ change processes from variations due to 
measurement error (and therefore regression to the mean), without at least a 3rd time point to 
estimate a trend.  Adjustment for the initial score provides some accounting for these factors. 
After adjustment, the strength of relationship between the change and mortality reached a level 
comparable to the scores at year 1 or 10.  
Our results overall show the HAI scores tend to increase with chronological age and variation in 
the change is related to subsequent mortality. These findings suggest the HAI is sensitive to 
physiologically relevant changes in health in aging, further supporting its utility as a measure of 
physiologic aging. However, adjustment for the year 10 score attenuated the relationship 
between the change and mortality. This implies, at least with the respect to mortality prediction, 
an individual’s trajectory to their current score adds little prognostic information to the score 
itself. Clinically, this suggests a current measurement in itself would give a useful indication of 
possible health risks in cases where a longer history is unavailable. 
Of the HAI components, only changes in DSST and cystatin C were related to mortality and only 
the DSST relationship remained after adjustment for year 10 score. Baseline measures of these 
variables have been identified as strong predictors of mortality in Health ABC (19). This 
heterogeneity of the change in HAI at the component level further helps to explain the more 
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modest relationship with mortality for the total change score. Blood pressure and glucose are 
extensively treated in this age group, making it more difficult to assess changes. The implications 
of these measures may also be different at advanced ages (20).  
Future studies may usefully explore strategies to refine the HAI to optimally capture change, for 
example by focusing on the most informative components or through component weighting by 
mortality rates or functional ability (5, 21). Another important area is to analyze changes across 
larger numbers of time points. As well as mean changes this will allow derivation of indices of 
variability and classification of groups following different health trajectories to more completely 
capture the heterogeneity of health changes in aging (22-25).  
In summary, HAI scores tended to increase with advancing age and predicted mortality from a 
given time-point, supporting the utility of the HAI as a summary measure of health in aging. 
Future studies to further characterize changes in the HAI and their relationships to health 
outcomes are warranted.    
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Tables 
Table 1: Description of participants at year 1 and year 10 
 
Full sample Year 10 sample 
  year 1 year 1 year 10 
n 2264 1122 1122 
HA Index & components 
   
HA Index score 4.8 (2.2) 4.3 (2.1) 5.7 (2.1) 
Systolic blood pressure, mmHG, mean (SD) 135.4 (20.5) 135.3 (20.1) 135.0 (19.0) 
Forced vital capacity, mL, mean (SD) 2890.9 (824.2) 2974.3 (800.1) 2606.8 (789.3) 
Digit symbol substitution test, points, mean (SD) 36.5 (14.4) 39.9 (13.6) 34.5 (14.1) 
Serum cystatin C*, mg/dL, mean (SD) 0.89 (0.28) 0.84 (0.18) 0.96 (0.33) 
Serum fasting glucose, mg/dL, mean (SD) 103.8 (33.7) 101.1 (29.9) 100.8 (24.5) 
    
Covariates 
   
Age, years, mean (SD) 73.6 (2.8) 73.1 (2.7) 82.1 (2.7) 
Female, n (%) 1164 (51.4) 594 (52.9) - 
Black race, n (%) 870 (38.4) 367 (32.7) - 
Pittsburgh site, n (%) 1172 (51.8) 599 (53.4) - 
Post secondary education, n (%) 1013 (44.9) 567 (50.5) - 
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Body Mass Index, kg/m2, mean (SD) 27.3 (4.7) 27.3 (4.6) 27.1 (4.8) 
Physical activity**, kcal/kg/week, median (IQR) 10.5 (3.5-24.3) 12.2 (4.2-26.2) 3.8 (0.5-11.6) 
20m gait speed, m/s, mean(SD)*** 1.3 (0.3) 1.4 (0.3) 1.0 (0.2) 
Current smoker, n (%) 210 (9.3) 69 (6.2) 37 (3.3) 
Cancer, n (%) 381 (16.9) 167 (14.9) 276 (24.6) 
Cardiovascular disease, n (%)  592 (26.7) 250 (22.7) 368 (32.8) 
Pulmonary disease, n (%) 242 (10.8) 90 (8.1) 144 (13.0) 
Depression (CES-D ≥10), n (%) 114 (5.1) 33 (3.0) 145 (13.4) 
Osteoporotic drug, n (%) 101 (4.5) 49 (4.4) 166 (14.8) 
Hip or knee osteoarthritis, n (%) 253 (11.3) 134 (12.1) 346 (31.0) 
Hypertension****, n (%) 1124 (50.0) 520 (46.6) 776 (69.2) 
Diabetes****, n (%) 325 (14.4) 125 (11.2) 185 (16.5) 
*From year 3  
**kcal/kg/week from walking, stairs & chores 
***From 2 minute walk at year 1 (n=2029) 
****From self-reported diagnosis or medication use 
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Table 2: Hazard ratios for Mortality by Healthy Aging Index scores from year 1, year 10 and the 
change between years 
  
Events/1000 
person years Model 1 Model 2 Model 3 
HA index score  yr 1         
Mortality from yr 3-17 (N=1436z/2264d) 
   
HR per unit index 
 
1.18 [1.14,1.21] 1.19 [1.15,1.23] 1.17 [1.13,1.21] 
HA index score 
    
0-2 (n=138z/333d) 33 1 1 1 
3-4 (n=384z/677d) 49 1.39 [1.14,1.69] 1.42 [1.16,1.74] 1.39 [1.13,1.71] 
5-6 (n=502z/737d) 67 1.91 [1.57,2.33] 1.94 [1.59,2.38] 1.81 [1.46,2.24] 
7-10 (n=412z/517d) 90 2.58 [2.10,3.18] 2.70 [2.17,3.36] 2.45 [1.94,3.08] 
HA index score yr 10 
    
Mortality from yr 10-17 (N=497z/1122d) 
   
HR per unit index 
 
1.23 [1.17,1.29] 1.24 [1.18,1.31] 1.20 [1.14,1.27] 
HA index score 
    
0-2 (n=18z/78d) 33 1 1 1 
3-4 (n=70z/237d) 43 1.24 [0.74,2.09] 1.39 [0.80,2.41] 1.39 [0.80,2.40] 
5-6 (n=163z/368d) 70 1.95 [1.19,3.20] 2.26 [1.34,3.84] 2.05 [1.21,3.47] 
7-10 (n=246z/439d) 100 2.75 [1.68,4.48] 3.18 [1.87,5.39] 2.66 [1.57,4.52] 
HA index change yr1-10 
    
Mortality from yr 10-17 (N=497z/1122d) 
   
HR per unit change 
 
1.09 [1.03,1.16] 1.08 [1.02,1.14] 1.08 [1.02,1.15] 
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HA index change score 
    
-4-0 (n=124z/311d) 63 1 1 1 
1 (n=125z/291d) 69 1.13 [0.88,1.45] 1.18 [0.91,1.53] 1.24 [0.95,1.61] 
2-3 (n=186/411d) 73 1.15 [0.91,1.44] 1.13 [0.89,1.44] 1.24 [0.97,1.59] 
4-8 (n=62z/109d) 102 1.77 [1.30,2.41] 1.62 [1.17,2.25] 1.55 [1.11,2.16] 
HA index change yr 1-10 and score at yr 1 
   
HR per unit change 
 
1.21 [1.14,1.29] 1.21 [1.13,1.30] 1.19 [1.11,1.27] 
HR per unit yr 1 score 
 
1.24 [1.17,1.30] 1.27 [1.19,1.35] 1.21 [1.14,1.29] 
HA index change yr 1-10 and score at yr 10 
   
HR per unit change 
 
0.98 [0.92,1.04] 0.95 [0.89,1.02] 0.98 [0.92,1.05] 
HR per unit yr 10 score 
 
1.24 [1.17,1.30] 1.27 [1.19,1.35] 1.21 [1.14,1.29] 
Model 1: age, sex, site, race, education 
Model 2: Model 1 + BMI, smoking, physical activity, cancer, cardiovascular disease, pulmonary disease, 
depression, osteoporotic drugs and hip or knee osteoarthritis,  
Model 3: Model 2 + gait speed 
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Table 3: Changes in Healthy Aging Index components and mortality 
HAI component Events/1000 person years Model 1 Model 2 Model 3 
Mortality from yr 10-17 (N=497/1122) 
   
SBP         
HR per unit change 
 
0.90 [0.79,1.02] 0.90 [0.79,1.03] 0.87 [0.75,1.00] 
Change score 
    
-1/-2 (n=28z/61d) 77 1 1 1 
0 (n=351z/772d) 74 1.02 [0.69,1.50] 0.97 [0.64,1.46] 0.77 [0.48,1.24] 
1 (n=81z/191d) 67 0.86 [0.55,1.32] 0.96 [0.61,1.52] 0.78 [0.47,1.29] 
2 (n=37z/98d) 58 0.81 [0.50,1.34] 0.70 [0.42,1.18] 0.54 [0.30,0.96] 
FVC         
HR per unit change 
 
1.08 [0.94,1.24] 1.08 [0.94,1.25] 0.96 [0.82,1.13] 
Change score 
    
-1/-2 (n=21z/45d) 75 1 1 1 
0 (n=265z/591d) 73 1.07 [0.69,1.69] 0.97 [0.61,1.55] 0.82 [0.51,1.32] 
1 (n=175z/421d) 66 1.05 [0.66,1.66] 0.98 [0.61,1.58] 0.74 [0.45,1.23] 
2 (n=36z/65d) 96 1.56 [0.90,2.70] 1.40 [0.79,2.51] 0.94 [0.51,1.76] 
DSST         
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HR per unit change 
 
1.53 [1.33,1.75] 1.41 [1.21,1.63] 1.22 [1.03,1.46] 
Change score 
    
-1/-2 (n=20z/82d) 35 1 1 1 
0 (n=275z/669d) 64 1.74 [1.10,2.74] 1.87 [1.14,3.08] 1.71 [1.04,2.82] 
1 (n=178z/336d) 92 2.44 [1.54,3.89] 2.45 [1.47,4.05] 1.88 [1.10,3.21] 
2 (n=24z/35d) 150 4.64 [2.56,8.42] 3.63 [1.86,7.08] 2.51 [1.23,5.11] 
Cystatin C         
HR per unit change 
 
1.14 [1.01,1.29] 1.15 [1.01,1.31] 1.04 [0.90,1.21] 
Change score 
    
-1/-2 (n=43z/99d) 72 1 1 1 
0 (n=279z/665d) 67 0.96 [0.69,1.32] 0.96 [0.68,1.34] 0.85 [0.60,1.21] 
1 (n=136z/287d) 76 1.08 [0.77,1.53] 1.10 [0.77,1.58] 0.89 [0.60,1.32] 
2 (n=39z/71d) 103 1.50 [0.97,2.31] 1.48 [0.93,2.36] 1.10 [0.66,1.84] 
Glucose         
HR per unit change 
 
1.01 [0.88,1.17] 1.02 [0.87,1.19] 0.86 [0.72,1.03] 
Change score 
   
 
-1/-2 (n=41z/89d) 74 1 1 1 
0 (n=342z/793d) 70 0.96 [0.69,1.33] 1.08 [0.74,1.56] 0.98 [0.67,1.42] 
1 (n=99z/206d) 78 1.00 [0.69,1.44] 1.12 [0.75,1.69] 0.84 [0.54,1.30] 
24 
 
2 (n=15z/34d) 69 1.00 [0.55,1.82] 0.96 [0.50,1.85] 0.60 [0.29,1.20] 
Model 1: age, sex, site, race, education       
Model 2: Model 1 + BMI, smoking, physical activity cancer, cardiovascular disease, pulmonary disease, 
depression, osteoporotic drugs, hip or knee osteoarthritis and gait speed 
Model 3: Model 2 + year 10 score for that component 
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Figures 
Figure 1: Summaries of changes in a Healthy Aging Index over 9 years   
1A: Distribution of the HAI at year 1 and year 10 
1B: Distribution of the change in HAI scores 
1C: Mean changes in HAI by baseline score 
Figure 2: Kaplan-Meier survival curves for Healthy Aging Index scores for year 1, year 10 
and the change between years 
2A: Mortality by HAI score from year 1 
2B: Mortality by HAI score from year 10 
2C: Mortality by HAI change score between years 
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